Search earnings tickers

REGN

2024Q3BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-10-31 · Fiscal end 2024-09-30 · Features as of 2024-10-30

← Earnings history

Street

Consensus EPS11.70

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.0%

IV front—

P/C full—

P/C front—

Features as of2024-10-30

Run-up

Close—

Ret 5d-2.0%

Ret 10d-8.4%

Ret 20d-11.3%

Ret 30d-19.0%

Print

Actual EPS

12.46Beat

Estimated EPS11.70

Actual revenue

3.7B

Surprise %+6.5%

Beat / missBeat

Beat streak 42

Beat streak 82

Reaction

1-day stock reaction-4.2%

Implied vs actual

Implied 2.0%Actual 5.2%

Gap reaction-5.2%

Day result-9.2%

Next-day upNo

Realized / IV2.53×

Post tape

Post 5d-1.6%

Post 10d-6.6%

Post volume2.3M

Vol ×10d2.97×

Vol ×20d3.30×

Post range7.7%